Mometasone/glycopyrronium/indacaterol
Mometasone/glycopyrronium/indacaterol was ranked 728th of 1,792 medicines by items in April 2026, with 2,481 items, up 11.4% on a year earlier.
Dispensed in April 2026
Rolling 12 months
Net ingredient cost · April 2026
Figure 1. Mometasone/glycopyrronium/indacaterol: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to April 2026
Embed this chart
At a glance
- Therapeutic class Corticosteroids (respiratory)
- Presentations 1 shown
- Average cost / item £50.76
- Year on year Up 11.4% on a year earlier
Top presentations, April 2026
The individual products dispensed under Mometasone/glycopyrronium/indacaterol this month.
| Presentation | BNF code | Items | Net ingredient cost |
|---|---|---|---|
| Enerzair Breezhaler 114microg / 46microg / 136microg/dose | 0302000W0BBAAAA | 2,481 | £125,935 |
Source: NHSBSA Prescription Cost Analysis · to April 2026 OGL v3.0
Where Mometasone/glycopyrronium/indacaterol is dispensed
The regions and dispensing practices with the highest Mometasone/glycopyrronium/indacaterol volumes.
Top regions
Top dispensing practices
Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.
Compare Mometasone/glycopyrronium/indacaterol with
Other medicines in the same BNF section, by prescribing volume.